- Home
- FGB vs PRE Comparison
FGB vs PRE Comparison
Compare FGB & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGB
- PRE
- Stock Information
- Founded
- FGB 2007
- PRE 2014
- Country
- FGB United States
- PRE Hong Kong
- Employees
- FGB N/A
- PRE N/A
- Industry
- FGB Finance/Investors Services
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- FGB Finance
- PRE Industrials
- Exchange
- FGB Nasdaq
- PRE Nasdaq
- Market Cap
- FGB 65.1M
- PRE 69.7M
- IPO Year
- FGB N/A
- PRE N/A
- Fundamental
- Price
- FGB $4.18
- PRE $4.40
- Analyst Decision
- FGB
- PRE Buy
- Analyst Count
- FGB 0
- PRE 1
- Target Price
- FGB N/A
- PRE $9.00
- AVG Volume (30 Days)
- FGB 53.0K
- PRE 8.0K
- Earning Date
- FGB 01-01-0001
- PRE 03-31-2025
- Dividend Yield
- FGB 8.92%
- PRE N/A
- EPS Growth
- FGB N/A
- PRE N/A
- EPS
- FGB N/A
- PRE N/A
- Revenue
- FGB N/A
- PRE $25,561,362.00
- Revenue This Year
- FGB N/A
- PRE $51.43
- Revenue Next Year
- FGB N/A
- PRE $131.29
- P/E Ratio
- FGB N/A
- PRE N/A
- Revenue Growth
- FGB N/A
- PRE N/A
- 52 Week Low
- FGB $2.85
- PRE $2.85
- 52 Week High
- FGB $3.74
- PRE $7.84
- Technical
- Relative Strength Index (RSI)
- FGB 32.89
- PRE 27.01
- Support Level
- FGB $4.45
- PRE $4.62
- Resistance Level
- FGB $4.50
- PRE $4.98
- Average True Range (ATR)
- FGB 0.08
- PRE 0.21
- MACD
- FGB -0.04
- PRE -0.06
- Stochastic Oscillator
- FGB 0.00
- PRE 17.05
About FGB First Trust Specialty Finance and Financial Opportunities Fund
First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.